.png?width=711&height=263&name=newsletterbanners%20(2).png)
FOR IMMEDIATE RELEASE
Functional Fluidics Showcases Breakthroughs in Red Blood Cell Health at Major Global Conferences This June
Detroit, MI – 6/5/25 – Functional Fluidics, a leader in red blood cell health innovation, is proud to announce upcoming presentations at major global scientific conferences this month, underscoring its ongoing commitment to advancing research and clinical solutions for individuals living with sickle cell disease (SCD) and other hematological conditions.
“We are honored to engage with the international hematology and sickle cell communities through these influential platforms,” said Dr. Patrick Hines, Founder and CEO of Functional Fluidics. “These meetings provide critical opportunities to share our latest scientific advancements, foster global partnerships, and accelerate progress in our mission to bring precision diagnostics to the forefront of red blood cell health.”
Functional Fluidics will present cutting-edge research at the following conferences:19th Annual Sickle Cell Disease (SCD) Symposium, June 7-9, 2025 - Florida, United States.
Title: Comparative Assessment of Biologic (Flow Adhesion of Whole Blood to P-selectin) and Clinical Response to Crizanlizumab in a Real-World Clinical Setting
- Poster Session Time: Sunday, June 8, 2025, 3:15 pm
- Presenter: Patrick Hines, MD/PhD, Founder & CEO, Functional Fluidics
Title: Preliminary Validation Of The Dynamic Sickling Assay (DSA) As A Diagnostic Tool For Assessing Sickle Cell Disease Severity And Monitoring Therapy Efficacy
- Abstract: PF1183
- Poster Session Time: Friday, June 13, 2025, 6:30-7:30 pm
- Presenter: Patrick Hines, MD/PhD, Founder & CEO, Functional Fluidics
- Abstract: PS2172
- Poster Session Time: Saturday, June 14, 2025, 6:30-7:30 pm
- Presenter: Jennell White, PhD, Senior Scientist, Functional Fluidics
Title: Preliminary Pharmacodynamic Biomarker Results In Patients With Sickle Cell Disease Following Treatment With Osivelotor In A Multicenter Phase 2/3 Trial
- Abstract: PS2166
- Poster Session Time: Saturday, June 14, 2025, 6:30 - 7:30 pm
- Presenter: Patrick Hines, MD/PhD, Founder & CEO, Functional Fluidics
- Abstract: PF1155
- Poster Session Time: Friday, June 13, 2025, 6:30 - 7:30 pm
- Presenter: Priya S. Chockalingam, PhD, Beam Therapeutics
Founded in 2014, Functional Fluidics is a precision health technology company specializing in red blood cell health, that leverages healthcare data and technologies to accelerate the development of life-changing therapies, support clinical trials, and bridge the gap between clinical research and patient care. The company has locations in North America and Sub-Saharan Africa and partners with healthcare providers, researchers, and pharmaceutical organizations globally.
About The Annual Sickle Cell Disease Research and Educational Symposium
The Annual Sickle Cell Disease Research and Educational Symposium is an exciting three-day meeting with over 400 attendees hosted by The Foundation for Sickle Cell Disease Research (FSCDR). Bringing together clinicians, researchers, advocates, and patients, the Symposium promotes collaboration, innovation, and education to improve outcomes and work toward a cure.
The Annual Sickle Cell Disease Research and Educational Symposium is an exciting three-day meeting with over 400 attendees hosted by The Foundation for Sickle Cell Disease Research (FSCDR). Bringing together clinicians, researchers, advocates, and patients, the Symposium promotes collaboration, innovation, and education to improve outcomes and work toward a cure.
About The European Hematology Association (EHA) Congress
The European Hematology Association (EHA) Congress is Europe's premier hematology event, convening over 14,000 professionals annually to share the latest advancements in research, clinical practice, and education. The 30th EHA Congress offers a hybrid format that combines in-person and virtual participation. This global forum fosters collaboration among hematologists, researchers, and healthcare professionals, aiming to accelerate progress in the field and improve patient outcomes worldwide.
Global Business Director
Functional Fluidics Inc.
Email: info@functionalfluidics.com
Website: [www.functionalfluidics.com]
The European Hematology Association (EHA) Congress is Europe's premier hematology event, convening over 14,000 professionals annually to share the latest advancements in research, clinical practice, and education. The 30th EHA Congress offers a hybrid format that combines in-person and virtual participation. This global forum fosters collaboration among hematologists, researchers, and healthcare professionals, aiming to accelerate progress in the field and improve patient outcomes worldwide.
Media Contact:
Nadine Russell, MBAGlobal Business Director
Functional Fluidics Inc.
Email: info@functionalfluidics.com
Website: [www.functionalfluidics.com]
